Mirum Pharmaceuticals, Inc. — Director's Dealing 2021

Nov 30, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Mirum Pharmaceuticals, Inc. (MIRM)
CIK: 0001759425
Period of Report: 2021-11-24

Reporting Person: Clements Ian (Chief Financial Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2021-11-24	Common Stock	P	700	$14.40	Acquired	17811	Direct
2021-11-26	Common Stock	P	750	$13.90	Acquired	18561	Direct

Footnotes

F1: The Reporting Person's purchases of MIRM common stock reported herein were matchable under Section 16(b) of the Securities Exchange Act of 1934 with the Reporting Person's sale of 1,574 shares of MIRM common stock on October 1, 2021 at a price of $19.256. The transactions resulted in short-swing profits of $7,416.20 which the Reporting Person has disgorged to MIRM in accordance with Section 16(b) of the Securities Exchange Act of 1934.